Abdominal Neoplasms
8
0
0
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
25%
2 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (8)
Malignant Pediatric Pelvic Tumors: A Retrospective Study
EUS GUIDED Transduodenal Biopsy Using the 19G Flex
22 Gauge Needle for EUS Guided Tissue Acquisition of Samples for Histologic Examination
Continuous Pre-peritoneal Wound Infiltration Versus Epidural Analgesia in Cancer Surgery
Augmented Pulse Pressure Variation to Predict Fluid Responsiveness in Open Laparotomy
Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors
Restricted Intravenous Fluid Regime Effects on Immunological Indicators of Elderly Patients Operated for Abdominal Cancer
Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery